Coral Laboratories Limited (BOM:524506)
422.85
-16.35 (-3.72%)
At close: Jan 21, 2026
Coral Laboratories Revenue
Coral Laboratories had revenue of 190.35M INR in the quarter ending September 30, 2025, a decrease of -40.94%. This brings the company's revenue in the last twelve months to 889.77M, down -19.73% year-over-year. In the fiscal year ending March 31, 2025, Coral Laboratories had annual revenue of 1.15B with 37.47% growth.
Revenue (ttm)
889.77M
Revenue Growth
-19.73%
P/S Ratio
1.75
Revenue / Employee
4.52M
Employees
197
Market Cap
1.56B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 1.15B | 313.45M | 37.47% |
| Mar 31, 2024 | 836.60M | 55.42M | 7.09% |
| Mar 31, 2023 | 781.19M | 25.08M | 3.32% |
| Mar 31, 2022 | 756.11M | -209.57M | -21.70% |
| Mar 31, 2021 | 965.67M | 259.88M | 36.82% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bilcare | 7.57B |
| Bal Pharma | 2.95B |
| Parnax Lab | 2.05B |
| Ambalal Sarabhai Enterprises | 1.97B |
| Lactose (India) | 1.37B |
| Astonea Labs | 1.17B |
| Oxygenta Pharmaceutical | 1.12B |
| Aayush Wellness | 1.11B |